NeurosciencebioRxivPreprint
A chemical screen identifies p38 MAPK inhibition as a candidate neuroprotective strategy for combinatorial SMA therapy
Maria Jose Carlini, Jorge Espinoza‐Derout, Meaghan Van Alstyne…·Livio Pellizzoni
This study identifies p38 MAPK inhibition as a neuroprotective strategy that synergizes with SMN upregulation to improve motor function and survival in SMA mice.
1 citation